Scientists at the cancer center City of Hope in California (USA) have discovered a chemical component in the shells that may decrease the risk of developing breast cancer positive for estrogen receptors, according to the results of his research papers appearing in the journal Cancer Prevention Research.
Specifically, these researchers have discovered ten natural compounds of this fruit could block aromatase, an enzyme that converts androgen into estrogen and play a “key role” in these tumors, explained Shiuan Chen, author of the research .
Despite this finding, Chen said that the compounds would not be a replacement for drugs, aromatase inhibitors (AIs), such as’ Aromasin ‘Pfizer’ Femara ‘Novartis’ or’ Arimidex ‘of AstraZeneca, as the compounds of the pomegranate “are not as powerful as real drugs.
The interest of this research “is probably more on prevention than on the therapeutic purpose,” Chen added.
Other researchers not connected with the study explained to the magazine that publishes the results are encouraging and suggested that will require more human and animal studies to confirm the findings.
“It is unclear whether these standards can be achieved in animals or humans because (compounds) are not well absorbed into the blood when they come through the diet,” said Gary Stoner at Ohio State University.
Previous research has shown that pomegranate juice is rich in antioxidants – vitamins and other substances – that would help prevent conditions such as cancer, heart disease and Alzheimer’s.
the link between vitamin D deficiency and breast cancer is very stong. See http://www.vitaminD3world.com for the info. The site also has links to to very neat micro tablet version of vitamin D